Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 32 min ago
Peer-reviewedCC BY 4.0Case Reports in Neurological Medicine

Progressive Multifocal Leukoencephalopathy Misdiagnosed as a Stroke

4 affiliations
  1. 1Wellcome-Wolfson Institute for Experimental Medicine Queen’s University Belfast Belfast UK qub.ac.uk
  2. 2Department of Medicine Lagan Valley Hospital Lisburn UK duhs.edu.pk
  3. 3Department of Neurology Ulster Hospital Dundonald UK setrust.hscni.net
  4. 4Department of Neuroradiology Royal Victoria Hospital Belfast UK nhs.uk

Abstract

Progressive multifocal leukoencephalopathy (PML) is rare and can be challenging to diagnose. Symptoms can be varied and can mimic stroke phenotypes. Physicians must hold a high index of suspicion in patients with significant PML risk factors (including HIV/AIDS, immunosuppression, lymphoproliferative malignancies and chemotherapy/monoclonal antibody therapies) presenting with progressive neurological symptoms. Here, we describe a 63‐year‐old man who presented with left‐sided weakness, apraxia and neglect on a background of subtle cognitive decline. He had a past medical history of recurrent follicular lymphoma with chemotherapy. He was initially diagnosed as a stroke but deteriorated further and ultimately received a diagnosis of PML. Earlier recognition of this condition will help to facilitate research into this disease.

Related

  1. Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients
    Emi Yokoyama, Taisuke Harada, Tomoyuki Endo +14
    International Journal of HematologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Immune checkpoints inhibitors in the treatment of progressive multifocal leukoencephalopathy: A systematic review and meta-analysis
    Ahmad Toubasi, Thuraya N. Al-Sayegh
    Neurological SciencesPeer-reviewedCC BY 4.0Full textOncologyPMC
  3. Treatment of Progressive Multifocal Leukoencephalopathy With Third-Party Allogeneic BK Virus T Cells
    Amanda Olson, Ye Li, David Marin +25
    Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of AmericaPeer-reviewedCC BY 4.0Full textClinical trials & evidence synthesisPMC
  4. Progressive multifocal leukoencephalopathy, bispecific antibodies, and multiple myeloma: a case report and systematic review of the literature
    Marina Tzanni, Panagiotis Polyzoidis, Konstantinos Angelopoulos +9
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  5. PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY DURING TECLISTAMAB THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Sabrina NAVROSKI, Pedro D'elia Machado SILVA, Erica Marquardt Lammerhirt OTTONI +1
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textOncologyDOAJ
BibTeX
@article{mullan2026progressive,
  title = {{Progressive Multifocal Leukoencephalopathy Misdiagnosed as a Stroke}},
  author = {Ger Mullan and Stephen Ramsay and Michael Jamison and Martin Harley and Simon Au},
  journal = {Case Reports in Neurological Medicine},
  year = {2026},
  month = nov,
  doi = {10.1155/crnm/6610404},
  url = {https://doi.org/10.1155/crnm/6610404},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Progressive Multifocal Leukoencephalopathy Misdiagnosed as a Stroke
AU  - Ger Mullan
AU  - Stephen Ramsay
AU  - Michael Jamison
AU  - Martin Harley
AU  - Simon Au
PY  - 2026
DA  - 2026/11/04
JO  - Case Reports in Neurological Medicine
DO  - 10.1155/crnm/6610404
UR  - https://doi.org/10.1155/crnm/6610404
AB  - Progressive multifocal leukoencephalopathy (PML) is rare and can be challenging to diagnose. Symptoms can be varied and can mimic stroke phenotypes. Physicians must hold a high index of suspicion in patients with significant PML risk factors (including HIV/AIDS, immunosuppression, lymphoproliferative malignancies and chemotherapy/monoclonal antibody therapies) presenting with progressive neurological symptoms. Here, we describe a 63‐year‐old man who presented with left‐sided weakness, apraxia and neglect on a background of subtle cognitive decline. He had a past medical history of recurrent follicular lymphoma with chemotherapy. He was initially diagnosed as a stroke but deteriorated further and ultimately received a diagnosis of PML. Earlier recognition of this condition will help to facilitate research into this disease.
SN  - 2090-6668
SN  - 2090-6676
ER  -